These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 17522406

  • 1. Prevention of death in COPD.
    Barnes PJ.
    N Engl J Med; 2007 May 24; 356(21):2211; author reply 2213-4. PubMed ID: 17522406
    [No Abstract] [Full Text] [Related]

  • 2. [Debates surrounding COPD].
    Tillie-Leblond I, Housset B.
    Rev Mal Respir; 2010 Feb 24; 27(2):106-7. PubMed ID: 20206057
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of death in COPD.
    Duerden M.
    N Engl J Med; 2007 May 24; 356(21):2212; author reply 2213-4. PubMed ID: 17526087
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of death in COPD.
    La Vecchia C, Fabbri LM.
    N Engl J Med; 2007 May 24; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of death in COPD.
    Kupfer Y, Tessler S.
    N Engl J Med; 2007 May 24; 356(21):2212-3; author reply 2213-4. PubMed ID: 17526086
    [No Abstract] [Full Text] [Related]

  • 6. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May 31; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract] [Full Text] [Related]

  • 7. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
    Doherty DE, Chapman KR, Martinez FJ, Belfer MH.
    J Fam Pract; 2007 Oct 31; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
    [No Abstract] [Full Text] [Related]

  • 8. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 9. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

  • 10. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
    Ecker-Schlipf B.
    Med Monatsschr Pharm; 2007 Nov 10; 30(11):428-9. PubMed ID: 18062342
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG.
    CMAJ; 2003 May 13; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract] [Full Text] [Related]

  • 12. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec 13; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 13. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 13; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 14. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S, Masoli M, Beasley R.
    J Allergy Clin Immunol; 2004 Feb 13; 113(2):219-20. PubMed ID: 14767433
    [No Abstract] [Full Text] [Related]

  • 15. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 16. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 22; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 17. Combined salmeterol and fluticasone for COPD.
    Khamis RY, Rajakulasingam RK.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
    Marchand E.
    Rev Mal Respir; 2010 Feb 10; 27(2):125-40. PubMed ID: 20206061
    [Abstract] [Full Text] [Related]

  • 19. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):322-3. PubMed ID: 18676961
    [No Abstract] [Full Text] [Related]

  • 20. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 15; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.